Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 397

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 1A
Chunk 397
---
 issued in connection with our IPO (the “Over-Allotment Option”) to purchase
up to 900,000 additional units to cover over-allotments (the “Over-Allotment Units”), if any. On February 21,
2023, the underwriters purchased 900,000 Over-Allotment Units fully exercising the Over-Allotment Option. The Over-Allotment Units were
sold at an offering price of $10.00 per Over-Allotment Unit, generating additional gross proceeds of $9,000,000 to the Company.

On October 16, 2024, the Company issued an unsecured promissory
note to Duksung Co., LTD. (“Duksung”) in the principal amount of $800,000 (the “Duksung Promissory Note”).
In the event of, and simultaneously with the closing of a Qualified PIPE Financing (as defined in the Duksung Promissory Note), the Duksung
Promissory Note automatically converts into Company common stock.

On February 25, 2025 we entered into an equity purchase agreement with
White Lion GBM Innovation Fund (the “ELOC Agreement”), providing that the Company has the right, but not the obligation,
to require White Lion to purchase, from time to time, up to the lesser of (i) $80,000,000 in aggregate gross purchase price of newly issued
shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), and (ii) the Exchange Cap, in
each case, subject to certain limitations and conditions set forth in the Common Stock Purchase Agreement. A more detailed discussion
of this agreement is included in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results
of Operations – Liquidity and Capital Resources.”

81

More detailed discussions of the Duksung Promissory Note and the ELOC
Agreement are included in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of
Operations – Liquidity and Capital Resources.”

Information about additional unregistered sales of our equity securities
in connection with the Business Combination is set forth under Item 2.01 of our Current Report on Form 8-K filed with the SEC on February
14, 2025.

Use of Proceeds from Registered Offerings 

On February 14, 2023, we consummated our initial public offering